Sequencing diverse populations revealed over 41,000 transcripts missing in Eurocentric references, exposing ancestry bias ...

Seq, a CRISPR-based method that enriches ultra-rare tumor DNA in blood by removing background wild-type DNA before sequencing ...

Recent industry reports have highlighted past and projected rapid expansion in the DNA diagnostics and genomics markets, driven by liquid biopsies, direct-to-consumer testing, and personalized ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its ...

Today we discuss why comparing U.S. vaccine policy to Europe’s is a red herring, why the revolving door at the FDA between ...

Liquid biopsy is increasingly recognized as a promising tool for cancer detection and treatment monitoring, yet its effectiveness is often limited by the extremely low levels of tumor-derived DNA ...

The NBDL represents a transition from observing nature as something external to something that is molecularly intimate.

Revvity targets 2026 growth with multiomics, AI-powered base editing, NGS newborn screening, and immunotherapy advances.

This article is all about what’s new and what it might mean for us, covering the latest in genetics in news. New methods like ...

NeoGenomics will present new data at ASH on how comprehensive genomic profiling supports diagnosis and treatment decisions in ...

The global genomics market is set to expand from USD 47.07 billion in 2025 to USD 85.09 billion by 2030, with a CAGR of 12.6%. Driven by increased government funding, rising disease prevalence, and ...